Generali Investments CEE’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.75M Sell
18,746
-1,586
-8% -$287K 0.13% 173
2026
Q1
$2.99M Sell
20,332
-1,226
-6% -$199K 0.16% 169
2025
Q4
$4.2M Sell
21,558
-7,468
-26% -$1.78M 0.3% 110
2025
Q3
$8.16M Sell
29,026
-474
-2% -$121K 0.62% 43
2025
Q2
$6.45M Hold
29,500
– – 0.53% 49
2025
Q1
$4.12M Hold
29,500
– – 0.38% 81
2024
Q4
$4.92M Buy
+29,500
New +$5.24M 0.51% 57

Other funds holding ORCL

Generali Investments CEE's ORCL Position: Q2 2026 in Review

Generali Investments CEE reduced its Oracle (ORCL) stake by 7.8% in Q2 2026, selling an estimated $287K and leaving 18,746 shares worth $2.75M. The position accounts for 0.13% of the portfolio, ranked #173.

Generali Investments CEE first reported a position in ORCL in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.16M in Q3 2025. 3,537 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Generali Investments CEE held 18,746 shares of Oracle worth $2.75M as of Q2 2026.
  • Generali Investments CEE sold 1,586 Oracle shares in Q2 2026, an estimated $287K.
  • Oracle made up 0.13% of Generali Investments CEE's portfolio in Q2 2026, its #173 holding.
  • Generali Investments CEE first reported a position in Oracle in Q4 2024 and has held it in 7 quarters since.
  • Generali Investments CEE's Oracle position peaked at $8.16M in Q3 2025.
  • 3,537 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Generali Investments CEE's 13F filing for Q2 2026, filed 13 Jul 2026.